Heron Therapeutics: Q4 Earnings Snapshot
In this article:
SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $10.7 million in its fourth quarter.
The San Diego-based company said it had a loss of 7 cents per share.
The pharmaceutical company posted revenue of $34.2 million in the period.
For the year, the company reported a loss of $110.6 million, or 80 cents per share. Revenue was reported as $127 million.
Heron Therapeutics expects full-year revenue in the range of $138 million to $158 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX
